Description

Correlation analysis between gut microbiota changes and symptom improvement in IBS patients following HMO supplementation, suggesting a microbiome-mediated mechanism.

Figure 5

Chart

Source Paper

The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel …

Nutrients (2021)

PMID: 34836092

DOI: 10.3390/nu13113836

Cite This Figure

![Figure 5: Correlation analysis between gut microbiota changes and symptom improvement in IBS patients following HMO supplementation, suggesting a microbiome-mediated mechanism.]()

> Source: Cristina Iribarren et al. "The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profile." *Nutrients*, 2021. PMID: [34836092](https://pubmed.ncbi.nlm.nih.gov/34836092/)

<figure>
  <img src="" alt="Correlation analysis between gut microbiota changes and symptom improvement in IBS patients following HMO supplementation, suggesting a microbiome-mediated mechanism." />
  <figcaption>Figure 5. Correlation analysis between gut microbiota changes and symptom improvement in IBS patients following HMO supplementation, suggesting a microbiome-mediated mechanism.<br>  Source: Cristina Iribarren et al. "The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profile." <em>Nutrients</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34836092/">34836092</a></figcaption>
</figure>

Preuves associées

Bifidobacterium longum pour Irritable Bowel Syndrome (IBS)

Note B · 4 études

Galactooligosaccharides (GOS) pour Irritable Bowel Syndrome (IBS)

Note B · 3 études